ArticleJTO clinical and research reports2021

Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases.

Jordi Remon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.